Ultrashort-echo-time (UTE) sequences have been proposed in the past for MR-based attenuation correction of PET data, because of their ability to image cortical bone. In the present work we assessed the limitations of dual-echo UTE imaging for bone segmentation in head and neck imaging. Sequentially acquired MR and PET/CT clinical data were used for this purpose. Methods: Twenty patients referred for a clinical oncology examination were scanned using a trimodality setup. Among the MR sequences, a dual-echo UTE acquisition of the head was acquired and used to create tissue R2 maps. The different undesired structures present in these maps were identified by an experienced radiologist. Global and local measurements of the overlap between R2-based and CT-based bone masks were computed. Results: UTE R2 maps displayed a nonfunctional relation with CT data. The obtained bone masks showed acceptable overlap with the corresponding CT data, in the case of the skull itself (e.g., 47% mismatch for the parietal region), with decreased performance in the base of the skull and in the neck (e.g., 78% for the maxillary region). Unwanted structures were detected, both anatomic (e.g., sternocleidomastoid, temporal, and masseter muscles) and artifactual (e.g., dental implants and air-tissue interfaces). Conclusion: It is indeed possible to estimate the anatomic location of bone tissue using UTE sequences. However, using pure parametric maps for attenuation correction may lead to bias close to certain anatomic structures and areas of high magnetic field inhomogeneity. More sophisticated approaches are necessary to compensate for these effects. Twel ve years after its commercial introduction, integrated PET/CT has evolved into one of the major imaging procedures in oncology, infection imaging, and cardiology. However, PET/CT has several limitations, both technical and diagnostic, that have recently led to the emergence of hybrid PET/MR scanners (1-3). Among other advantages, PET/MR imaging offers superior soft-tissue contrast (e.g., higher sensitivity for small liver metastases, additional information for lesion characterization, and better depiction of pelvic structures) and lower radiation exposure to the patient. There are, however, several technical and clinical challenges that have to be solved before this modality can reach its full potential.One of the main topics of controversy is how the attenuation correction of the PET images should be addressed (4-6). PET/CT machines provide the possibility of generating the annihilation photon attenuation map of the patient from a fast low-dose CT scan. This has replaced the former slow measurement of this map by means of external 511-keV radiation sources, thus significantly reducing the total scan time.Several approaches are currently being investigated to generate valid annihilation photon attenuation maps from fast MR sequences (7-11). Comprehensive reviews of current MR-based attenuation correction methods, their advantages and limitations, are available in the literature (12,13).MR-...